A MULTICENTRIC, DOUBLE-BLIND, RANDOMISED-CONTROLLED TRIAL (RCT) OF HIGH DOSE URSODEOXYCHOLIC ACID IN PATIENTS WITH NON-ALCOHOLIC STEATOHEPATITIS (NASH)

被引：6
|
作者：
Ratziu, V. [1 ]
De Ledinghen, V. [2 ]
Oberti, F. [3 ]
Mathurin, P. [4 ]
Wartelle-Bladou, C. [5 ]
Renou, C. [6 ]
Spenard, J. [7 ,8 ]
机构：
[1] Hop La Pitie Salpetriere, Serv Hepatogastroenterol, Paris, France
[2] Hop Haut Leveque, Serv Hepatogastroenterol, Pessac, France
[3] CHU Angers, Serv Hepatogastroenterol, Angers, France
[4] Ctr Hosp Reg & Univ Lille, Hop Huriez, Serv Malad Appareil Digestif, F-59037 Lille, France
[5] CHG Pays Aix, Serv Hepatogastroenterol, Aix En Provence, France
[6] CH Hyeres, Unite Hepatogastroenterol, Hyeres, France
[7] Axcan Pharma, Mt St Hilaire, PQ, Canada
[8] Univ Montreal, Dept Pharmacol, Fac Med, Montreal, PQ H3C 3J7, Canada
来源：
JOURNAL OF HEPATOLOGY | 2009年 / 50卷
关键词：
D O I：
10.1016/S0168-8278(09)60049-0
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
47
引用
收藏
页码：S21 / S21
页数：1
相关论文
共 50 条
  • [1] A Multicentric, Double-Blind, Randomized Placebo-Controlled Trial of High Dose Ursodeoxycholic Acid in Patients with Non-Alcoholic Steatohepatitis (NASH)
    Ratziu, Vlad
    De Ledinghen, Victor
    Frederic, Oberti
    Mathurin, Philippe
    Bladou, Claire Wartelle
    Renou, Christophe
    Spenard, Jean
    GASTROENTEROLOGY, 2009, 136 (05) : A846 - A846
  • [2] A multicentric, double-blind, randomised-controlled trial (RCT) of carnitine orotate complex in diabetic patients with non-alcoholic fatty liver disease (NAFLD)
    Bae, J.
    Lee, W.
    Yoon, K.
    Park, J.
    Son, H.
    Han, K.
    Lee, K.
    Woo, J. -T.
    Lee, M. -K.
    DIABETOLOGIA, 2014, 57 : S349 - S350
  • [3] A double-blind, placebo-controlled trial of pioglitazone in the treatment of non-alcoholic steatohepatitis (NASH)
    Harrison, S
    Belfort, R
    Brown, K
    Darland, C
    Finch, J
    Fincke, C
    Havranek, R
    Hardies, J
    Dwivedi, S
    Berria, R
    Tio, FM
    Schenker, S
    Cusi, K
    GASTROENTEROLOGY, 2005, 128 (04) : A681 - A681
  • [4] Is high-dose Ursodeoxycholic Acid effective in Patients with non-alcoholic Steatohepatitis?
    Walldorf, J.
    Dollinger, M. M.
    GASTROENTEROLOGE, 2010, 5 (06): : 538 - 539
  • [5] A MULTICENTER, DOUBLE-BLIND, PLACEBO-CONTROLLED, RANDOMIZED TRIAL OF EMRICASAN IN SUBJECTS WITH NON-ALCOHOLIC STEATOHEPATITIS (NASH) AND FIBROSIS
    Harrison, Stephen A.
    Goodman, Zachary D.
    Jabbar, Abdul
    Younes, Ziad
    Vemulapalli, Ravi
    Freilich, Bradley L.
    Sheikh, Muhammad Y.
    Schattenberg, Joern
    Kayali, Zeid
    Zivony, Adam Seth
    Sheikh, Aasim M.
    Garcia-Samaniego, Javier
    Satapathy, Sanjaya Kumar
    Therapondos, George
    Mena, Edward A.
    Schuppan, Detlef
    Robinson, James M.
    Chan, Jean Lin
    Hagerty, David
    Sanyal, Arun J.
    HEPATOLOGY, 2019, 70 : 43A - 44A
  • [6] Ursodeoxycholic acid and gemfibrozil in the treatment of non-alcoholic steatohepatitis: A randomized controlled trial
    Cicek, B
    Koksal, A
    Oguz, D
    Erden, E
    Sahin, T
    JOURNAL OF HEPATOLOGY, 2004, 40 : 169 - 170
  • [7] Silymarin in non-cirrhotics with non-alcoholic steatohepatitis: A randomized, double-blind, placebo controlled trial
    Navarro, Victor J.
    Belle, Steven H.
    D'Amato, Massimo
    Adfhal, Nezam
    Brunt, Elizabeth M.
    Fried, Michael W.
    Reddy, K. Rajender
    Wahed, Abdus S.
    Harrison, Stephen
    PLOS ONE, 2019, 14 (09):
  • [8] High-Dose Ursodeoxycholic Acid Therapy for Nonalcoholic Steatohepatitis: A Double-Blind, Randomized, Placebo-Controlled Trial
    Leuschner, Ulrich F. H.
    Lindenthal, Birgit
    Herrmann, Guenter
    Arnold, Joachim C.
    Roessle, Martin
    Cordes, Hans-Joerg
    Zeuzem, Stefan
    Hein, Jasper
    Berg, Thomas
    HEPATOLOGY, 2010, 52 (02) : 472 - 479
  • [9] Probucol in the treatment of non-alcoholic steatohepatitis: a double-blind randomized controlled study
    Merat, S
    Malekzadeh, R
    Sohrabi, MR
    Sotoudeh, M
    Rakhshani, N
    Sohrabpour, AA
    Naserimoghadam, S
    JOURNAL OF HEPATOLOGY, 2003, 38 (04) : 414 - 418
  • [10] High-dose ursodeoxycholic acid in primary sclerosing cholangitis a randomised double-blind placebo-controlled trial
    Bansi, D
    Christie, J
    Fleming, K
    Chapman, R
    GASTROENTEROLOGY, 1996, 110 (04) : A1146 - A1146
12345